These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37225644)

  • 1. NKX3.1 immunohistochemistry and methylome profiling in mesenchymal chondrosarcoma: additional diagnostic value for a well-defined disease?
    Glauser S; Ameline B; Andrei V; Harder D; Pauli C; Trautmann M; Hartmann W; Baumhoer D
    Pathology; 2023 Aug; 55(5):621-628. PubMed ID: 37225644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
    Syed M; Mushtaq S; Loya A; Hassan U
    Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population.
    Ramanayake N; Vargas AC; Talbot J; Bonar F; Wong DD; Wong D; Mahar A; Karim R; Luk PP; Selinger C; Sioson L; Gill AJ; Maclean F
    Pathology; 2021 Oct; 53(6):705-712. PubMed ID: 33640159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases.
    Yao K; Duan Z; Yang S; Du Z; Wang Y; Qi X
    J Neuropathol Exp Neurol; 2020 Sep; 79(9):959-965. PubMed ID: 32770197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25-case cohort study.
    Chen W; Hornick JL; Fletcher CDM
    Histopathology; 2021 Jan; 78(2):334-337. PubMed ID: 32779239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic involvement by mesenchymal chondrosarcoma harboring the HEY1-NCOA2 gene fusion.
    Cohen JN; Solomon DA; Horvai AE; Kakar S
    Hum Pathol; 2016 Dec; 58():35-40. PubMed ID: 27544802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal chondrosarcoma diagnosed on FISH for HEY1-NCOA2 fusion gene.
    Moriya K; Katayama S; Onuma M; Rikiishi T; Hosaka M; Watanabe M; Hasegawa T; Sasahara Y; Kure S
    Pediatr Int; 2014 Oct; 56(5):e55-7. PubMed ID: 25336010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal chondrosarcoma of the head and neck with HEY1::NCOA2 fusion: A clinicopathologic and molecular study of 13 cases with emphasis on diagnostic pitfalls.
    Xu B; Rooper LM; Dermawan JK; Zhang Y; Suurmeijer AJH; Dickson BC; Demicco EG; Antonescu CR
    Genes Chromosomes Cancer; 2022 Nov; 61(11):670-677. PubMed ID: 35672279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HEY1-NCOA2 expression modulates chondrogenic differentiation and induces mesenchymal chondrosarcoma in mice.
    Tanaka M; Homme M; Teramura Y; Kumegawa K; Yamazaki Y; Yamashita K; Osato M; Maruyama R; Nakamura T
    JCI Insight; 2023 May; 8(10):. PubMed ID: 37212282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: A mesenchymal chondrosarcoma with alternative
    Kishikawa S; Kondo A; Yao T; Saito T
    Pathol Oncol Res; 2024; 30():1611730. PubMed ID: 39165647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minute mesenchymal chondrosarcoma within osteochondroma: an unexpected diagnosis confirmed by HEY1-NCOA2 fusion.
    Toki S; Motoi T; Miyake M; Kobayashi E; Kawai A; Yoshida A
    Hum Pathol; 2018 Nov; 81():255-260. PubMed ID: 29596896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.
    Qi W; Rosikiewicz W; Yin Z; Xu B; Jiang H; Wan S; Fan Y; Wu G; Wang L
    J Pathol; 2022 Aug; 257(5):579-592. PubMed ID: 35342947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma.
    Yoshida KI; Machado I; Motoi T; Parafioriti A; Lacambra M; Ichikawa H; Kawai A; Antonescu CR; Yoshida A
    Am J Surg Pathol; 2020 Jun; 44(6):719-728. PubMed ID: 31972596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
    de Andrea CE; San-Julian M; Bovée JVMG
    Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma.
    Nakayama R; Miura Y; Ogino J; Susa M; Watanabe I; Horiuchi K; Anazawa U; Toyama Y; Morioka H; Mukai M; Hasegawa T
    Pathol Int; 2012 Dec; 62(12):823-6. PubMed ID: 23252872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
    Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.
    Wang L; Motoi T; Khanin R; Olshen A; Mertens F; Bridge J; Dal Cin P; Antonescu CR; Singer S; Hameed M; Bovee JV; Hogendoorn PC; Socci N; Ladanyi M
    Genes Chromosomes Cancer; 2012 Feb; 51(2):127-39. PubMed ID: 22034177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of mesenchymal chondrosarcoma in pleural effusion with immunocytochemistry and determination of HEY1::NCOA2 fusion by next-generation sequencing on cell block.
    Zhong J; Wang Q; Xie Y; Niu Z; Zhou D
    Cytopathology; 2024 Jan; 35(1):149-152. PubMed ID: 37688410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and diagnostic value of NKX3.1 and NKX2.2 in mesenchymal chondrosarcoma].
    Wang XX; Chen H; Wang X; Ma L; Cheng K; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):114-119. PubMed ID: 35152629
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel low-grade renal spindle cell neoplasm with HEY1::NCOA2 fusion that is distinct from mesenchymal chondrosarcoma.
    Miller TI; Mantilla JG; Wang W; Liu YJ; Tretiakova M
    Genes Chromosomes Cancer; 2023 Mar; 62(3):171-175. PubMed ID: 36416671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.